BioPorto A/S (CPH:BIOPOR)
Denmark
· Delayed Price · Currency is DKK 1.055
+0.061 (6.14%)
Apr 29, 2026, 10:00 AM CET
BioPorto Employees
BioPorto had 46 employees as of December 31, 2025. The number of employees decreased by 2 or -4.17% compared to the previous year.
Employees
46
Change (1Y)
-2
Growth (1Y)
-4.17%
Revenue / Employee
875.80K DKK
Profits / Employee
-1.79M DKK
Market Cap
492.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Genmab | 2,973 |
| Coloplast | 16,983 |
| ALK-Abelló | 2,613 |
| ChemoMetec | 172 |
| Gubra | 300 |
| ViroGates | 7 |
| Pharma Equity Group | 5 |
BioPorto News
- 4 weeks ago - BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis - GlobeNewsWire
- 4 weeks ago - Notice convening the Annual General Meeting in BioPorto A/S - GlobeNewsWire
- 4 weeks ago - BioPorto announces the Annual Report for 2025 - GlobeNewsWire
- 5 weeks ago - BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026 - GlobeNewsWire
- 2 months ago - BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update - GlobeNewsWire
- 5 months ago - BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes - GlobeNewsWire
- 5 months ago - Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S - GlobeNewsWire
- 5 months ago - BioPorto Executes on its Financing Strategy- BioPorto A/S initiates pre-subscribed private placement - GlobeNewsWire